Bollard Group LLC Paratek Pharmaceuticals, Inc. Transaction History

Bollard Group LLC

  • $3.76 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.73 - $3.09 $3,735 - $6,671
-2,159 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$4.19 - $6.69 $28,550 - $45,585
-6,814 Reduced 75.94%
2,159 $12,000
Q2 2020

Aug 13, 2020
BUY
$2.97 - $5.22 $26,649 - $46,839
8,973 New
8,973 $47,000

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email